Evaluation of the protection conferred by a naturally attenuated Neospora caninum isolate against congenital and cerebral neosporosis in mice

Veterinary Research

Volumn 43, Issue 1, 2012, Pages

  Rojo Montejo, Silvia ^a   Collantes Fernández, Esther ^a   Lápez Pérez, Inmaculada ^a   Risco Castillo, Veránica ^a   Prenafeta, Antoni ^b   Ortega Mora, Luis Miguel ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b LABORATORIOS HIPRA S A   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN G; LIVE VACCINE; PARASITE ANTIGEN; PROTOZOAL DNA; PROTOZOAL VACCINE; PROTOZOON ANTIBODY;

ANIMAL; ANIMAL DISEASE; ARTICLE; BAGG ALBINO MOUSE; BLOOD; BRAIN; COCCIDIOSIS; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETICS; HUMORAL IMMUNITY; IMMUNOLOGY; METABOLISM; MOUSE; NEOSPORA; PARASITOLOGY; PATHOGENICITY; PATHOLOGY; POLYMERASE CHAIN REACTION; PREGNANCY; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; BRAIN; COCCIDIOSIS; CYTOKINES; DNA, PROTOZOAN; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNITY, HUMORAL; IMMUNOGLOBULIN G; INJECTIONS, SUBCUTANEOUS; MICE; MICE, INBRED BALB C; NEOSPORA; POLYMERASE CHAIN REACTION; PREGNANCY; PROTOZOAN VACCINES; VACCINES, ATTENUATED;

EID: 84867297208     PISSN: 09284249     EISSN: 12979716     Source Type: Journal    
DOI: 10.1186/1297-9716-43-62     Document Type: Article

References (50)

1. If control of Neospora caninum infection is technically feasible does it make economic sense? Reichel MP, Ellis JT, Vet Parasitol 2006 142 23 34 10.1016/j.vetpar.2006.06.027 16893606 (Pubitemid 44584534)
2. Developing vaccines to control protozoan parasites in ruminants: dead or alive? Innes EA, Bartley PM, Rocchi M, Benavidas-Silvan J, Burrells A, Hotchkiss E, Chianini F, Canton G, Katzer F, Vet Parasitol 2011 180 155 163 10.1016/j.vetpar.2011.05.036 21680094
3. Characterization of temperature-sensitive strains of Neospora caninum in mice. Lindsay DS, Lenz SD, Blagburn BL, Brake DA, J Parasitol 1999 85 64 67 10207365 (Pubitemid 29241884)
4. Long-term passage of tachyzoites in tissue culture can attenuate virulence of Neospora caninum in vivo. Bartley PM, Wright S, Sales J, Chianini F, Buxton D, Innes EA, Parasitology 2006 133 421 432 10.1017/S0031182006000539 16762097 (Pubitemid 44605834)
5. Vaccination with gamma-irradiated Neospora caninum tachyzoites protects mice against acute challenge with N. caninum. Ramamoorthy S, Lindsay DS, Schurig GG, Boyle SM, Duncan RB, Vemulapalli R, Sriranganathan N, J Eukaryot Microbiol 2006 53 151 156 10.1111/j.1550-7408.2005.00083.x 16579818 (Pubitemid 43357019)
6. Characterisation of the first Australian isolate of Neospora caninum from cattle. Miller CM, Quinn HE, Windsor PA, Ellis JT, Aust Vet J 2002 80 620 625 10.1111/j.1751-0813.2002.tb10967.x 12465814 (Pubitemid 135746649)
7. Pathogenic characterization in mice of Neospora caninum isolates obtained from asymptomatic calves. Pereira García-Melo D, Regidor-Cerrillo J, Collantes-Fernández E, Aguado-Martínez A, Del Pozo I, Minguiján E, Gámez-Bautista M, Aduriz G, Ortega-Mora LM, Parasitology 2010 137 1057 1068 10.1017/S0031182009991855 20233488
8. Isolation and characterization of a bovine isolate of Neospora caninum with low virulence. Rojo-Montejo S, Collantes-Fernández E, Regidor-Cerrillo J, Álvarez-García G, Marugán- Hernández V, Pedraza-Díaz S, Blanco-Murcia J, Prenafeta A, Ortega-Mora LM, Vet Parasitol 2009 159 7 16 10.1016/j.vetpar.2008.10.009 19027235
9. Influence of Neospora caninum intra-specific variability in the outcome of infection in a pregnant BALB/c mouse model. Regidor-Cerrillo J, Gámez-Bautista M, Del Pozo I, Jiménez-Ruiz E, Aduriz G, Ortega-Mora LM, Vet Res 2010 41 52 10.1051/vetres/2010024 20416260
10. In vitro invasion efficiency and intracellular proliferation rate comprise virulence-related phenotypic traits of Neospora caninum. Regidor-Cerrillo J, Gámez-Bautista M, Sodupe I, Aduriz G, Álvarez-García G, Del Pozo I, Ortega-Mora LM, Vet Res 2011 42 41 10.1186/1297-9716-42-41 21345202
11. Experimental infection with a low virulence isolate of Neospora caninum at 70days gestation in cattle did not result in foetopathy. Rojo-Montejo S, Collantes-Fernández E, Blanco-Murcia J, Rodríguez-Bertos A, Risco-Castillo V, Ortega-Mora LM, Vet Res 2009 40 49 10.1051/vetres/2009032 19497257
12. The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-alpha beta-transgenic model. Hosken NA, Shibuya K, Heath AW, Murphy KM, OGarra A, J Exp Med 1995 182 1579 1584 10.1084/jem.182.5.1579 7595228
13. Influence of adjuvant and antigen dose on protection induced by an inactivated whole vaccine against Neospora caninum infection in mice. Rojo-Montejo S, Collantes-Fernández E, Regidor-Cerrillo J, Rodríguez-Bertos A, Prenafeta A, Gámez-Bautista M, Ortega-Mora LM, Vet Parasitol 2011 175 220 229 10.1016/j.vetpar.2010.10.028 21067865
14. Characterization of the first European isolate of Neospora caninum (Dubey, Carpenter, Speer, Topper and Uggla). Barber JS, Holmdahl OJ, Owen MR, Guy F, Uggla A, Trees AJ, Parasitology 1995 111 563 568 10.1017/ S0031182000077039 8559588 (Pubitemid 26029500)
15. Adaptation of Neospora caninum isolates to cell-culture changes: an argument in favor of its clonal population structure. Pérez-Zaballos FJ, Ortega-Mora LM, Álvarez-García G, Collantes-Fernández E, Navarro-Lozano V, García-Villada L, Costas E, J Parasitol 2005 91 507 510 10.1645/GE-381R1 16108539 (Pubitemid 40993435)
16. Temporal distribution and parasite load kinetics in blood and tissues during Neospora caninum infection in mice. Collantes-Fernández E, Lápez-Pérez I, Álvarez-García G, Ortega-Mora LM, Infect Immun 2006 74 2491 2494 10.1128/IAI.74.4.2491-2494.2006 16552086
17. Comparative effect of Neospora caninum infection in BALB/c mice at three different gestation periods. Lápez-Pérez IC, Risco-Castillo V, Collantes-Fernández E, Ortega-Mora LM, J Parasitol 2006 92 1286 1291 10.1645/GE-883R.1 17304808
18. Influence of Neospora caninum infection in BALB/c mice during pregnancy in post-natal development. Lápez-Pérez IC, Collantes- Fernández E, Aguado-Martínez A, Rodríguez-Bertos A, Ortega-Mora LM, Vet Parasitol 2008 155 175 183 10.1016/j.vetpar.2008.05.018 18586405
19. Effect of exteroceptive factors on the oestrous cycle of mice. Whitten MK, Nature 1957 180 1436 13493564
20. Failure of a vaccine using immunogenic recombinant proteins rNcSAG4 and rNcGRA7 against neosporosis in mice. Aguado-Martínez A, Álvarez-García G, Fernández-García A, Risco-Castillo V, Marugán-Hernández V, Ortega-Mora LM, Vaccine 2009 27 7331 7338 10.1016/j.vaccine.2009.09.050 19782735
21. Comparative efficacy of immunization with inactivated whole tachyzoites versus a tachyzoite-bradyzoite mixture against neosporosis in mice. Rojo-Montejo S, Collantes-Fernández E, Rodríguez-Marcos S, Pérez-Zaballos F, Lápez-Pérez I, Prenafeta A, Ortega-Mora LM, Parasitology 2011 138 1372 1383 10.1017/S0031182011001156 21810300
22. The pathogenesis of experimental neosporosis in pregnant sheep. Buxton D, Maley SW, Wright S, Thomson KM, Rae AG, Innes EA, J Comp Pathol 1998 118 267 279 10.1016/S0021-9975(07)80003-X 9651804 (Pubitemid 28260698)
23. Multilocus microsatellite analysis reveals extensive genetic diversity in Neospora caninum. Regidor-Cerrillo J, Pedraza-Díaz S, Gámez-Bautista M, Ortega-Mora LM, J Parasitol 2006 92 517 524 10.1645/GE-713R.1 16883994 (Pubitemid 44141257)
24. Microsatellite markers for the molecular characterization of Neospora caninum: application to clinical samples. Pedraza-Díaz S, Marugán-Hernández V, Collantes-Fernández E, Regidor-Cerrillo J, Rojo-Montejo S, Gámez-Bautista M, Ortega-Mora LM, Vet Parasitol 2009 166 38 46 10.1016/j.vetpar.2009.07.043 19720464
25. Comparison of intracerebral parasite load, lesion development, and systemic cytokines in mouse strains infected with Neospora caninum. Long MT, Baszler TV, Mathison BA, J Parasitol 1998 84 316 320 10.2307/3284489 9576505 (Pubitemid 28217408)
26. Survival probabilities (the Kaplan-Meier method). Bland JM, Altman DG, BMJ 1998 317 1572 10.1136/bmj.317.7172.1572 9836663 (Pubitemid 128719735)
27. The logrank test. Bland JM, Altman DG, BMJ 2004 328 1073 10.1136/bmj.328.7447.1073 15117797
28. Finney DJ, Probit analysis Cambridge University Press, London 1971
29. Vaccination of sheep with a live incomplete strain (S48) of Toxoplasma gondii and their immunity to challenge when pregnant. Buxton D, Thomson K, Maley S, Wright S, Bos HJ, Vet Rec 1991 129 89 93 10.1136/vr.129.5.89 1926725
30. Reduction in transplacental transmission of Neospora caninum in outbred mice by vaccination. Miller C, Quinn H, Ryce C, Reichel MP, Ellis JT, Int J Parasitol 2005 35 821 828 10.1016/j.ijpara.2005.03.006 15885695 (Pubitemid 40733621)
31. Immunization of cattle with live tachyzoites of Neospora caninum confers protection against fetal death. Williams DJ, Guy CS, Smith RF, Ellis J, Bjorkman C, Reichel MP, Trees AJ, Infect Immun 2007 75 1343 1348 10.1128/IAI.00777-06 17145943 (Pubitemid 46385827)
32. Neospora caninum-how close are we to development of an efficacious vaccine that prevents abortion in cattle? Reichel MP, Ellis JT, Int J Parasitol 2009 39 1173 1187 10.1016/j.ijpara.2009.05.007 19497326
33. The development of immune responses in Balb/c mice following inoculation with attenuated or virulent Neospora caninum tachyzoites. Bartley PM, Wright SE, Maley SW, Buxton D, Nath M, Innes EA, Parasite Immunol 2009 31 392 401 10.1111/j.1365-3024.2009.01115.x 19527455
34. Proteome expression changes among virulent and attenuated Neospora caninum isolates. Regidor-Cerrillo J, Álvarez-García G, Pastor-Fernández I, Marugán-Hernández V, Gámez-Bautista M, Ortega-Mora LM, J Proteomics 2012 75 2306 2318 10.1016/j.jprot.2012.01.039 22343075
35. Neospora caninum: role for immune cytokines in host immunity. Khan IA, Schwartzman JD, Fonseka S, Kasper LH, Exp Parasitol 1997 85 24 34 10.1006/expr.1996.4110 9024199 (Pubitemid 27236711)
36. The inhibitory effect of interferon gamma and tumor necrosis factor alpha on intracellular multiplication of Neospora caninum in primary bovine brain cells. Yamane I, Kitani H, Kokuho T, Shibahara T, Haritani M, Hamaoka T, Shimizu S, Koiwai M, Shimura K, Yokomizo Y, J Vet Med Sci 2000 62 347 351 10.1292/jvms.62.347 10770613
37. In the absence of endogenous gamma interferon, mice acutely infected with Neospora caninum succumb to a lethal immune response characterized by inactivation of peritoneal macrophages. Nishikawa Y, Tragoolpua K, Inoue N, Makala L, Nagasawa H, Otsuka H, Mikami T, Clin Diagn Lab Immunol 2001 8 811 816 11427432
38. Susceptibility of B-cell deficient C57BL/6 (microMT) mice to Neospora caninum infection. Eperon S, Bronnimann K, Hemphill A, Gottstein B, Parasite Immunol 1999 21 225 236 10.1046/j.1365-3024.1999.00223.x 10320620 (Pubitemid 29199811)
39. The cell-mediated immune response to Neospora caninum during pregnancy in the mouse is associated with a bias towards production of interleukin-4. Quinn HE, Miller CM, Ellis JT, Int J Parasitol 2004 34 723 732 10.1016/j.ijpara.2004. 01.007 15111094 (Pubitemid 38521227)
40. Inoculation of Balb/c mice with live attenuated tachyzoites protects against a lethal challenge of Neospora caninum. Bartley PM, Wright S, Chianini F, Buxton D, Innes EA, Parasitology 2008 135 13 21 17767798 (Pubitemid 350273743)
41. Immunisation of mice against neosporosis. Lundén A, Wright S, Allen JE, Buxton D, Int J Parasitol 2002 32 867 876 10.1016/S0020-7519(02)00024- 3 12062558 (Pubitemid 34615880)
42. Transgenic Neospora caninum strains constitutively expressing the bradyzoite NcSAG4 protein proved to be safe and conferred significant levels of protection against vertical transmission when used as live vaccines in mice. Marugán-Hernández V, Ortega-Mora LM, Aguado-Martínez A, Jiménez-Ruiz E, Álvarez-García G, Vaccine 2011 29 7867 7874 10.1016/j.vaccine.2011.07.091 21816191
43. Genetic diversity amongst isolates of Neospora caninum, and the development of a multiplex assay for the detection of distinct strains. Al-Qassab S, Reichel MP, Ivens A, Ellis JT, Mol Cell Probes 2009 23 132 139 10.1016/j.mcp.2009.01.006 19496247
44. Anti-IL-4 antibody therapy causes regression of chronic lesions caused by medium-dose Leishmania major infection in BALB/c mice. Uzonna JE, Bretscher PA, Eur J Immunol 2001 31 3175 3184 10.1002/1521-4141(200111)31:11<3175::AID- IMMU3175>3.0.CO;2-L 11745334 (Pubitemid 33100509)
45. Low dose Leishmania major promotes a transient T helper cell type 2 response that is down-regulated by interferon gamma-producing CD8+ T cells. Uzonna JE, Joyce KL, Scott P, J Exp Med 2004 199 1559 1566 10.1084/jem.20040172 15184505 (Pubitemid 38780410)
46. Imprinting of BALB/c mice with low Leishmania infantum parasite dose markedly protects spleen against high-dose challenge. Ferrua B, Luci C, Le Fichoux Y, Paul A, Marty P, Vaccine 2006 24 589 596 10.1016/j.vaccine.2005.08. 057 16157427 (Pubitemid 43017824)
47. Effect of dose and route of inoculation on the generation of CD4+ Th1/Th2 type of immune response in murine visceral leishmaniasis. Kaur S, Kaur T, Garg N, Mukherjee S, Raina P, Athokpam V, Parasitol Res 2008 103 1413 1419 10.1007/s00436-008-1150-x 18751727
48. Interferon-gamma and interleukin-12 mediate protection to acute Neospora caninum infection in BALB/c mice. Baszler TV, Long MT, McElwain TF, Mathison BA, Int J Parasitol 1999 29 1635 1646 10.1016/S0020-7519(99)00141-1 10608450 (Pubitemid 29528174)
49. Erythrocyte invasion by Babesia bovis merozoites is inhibited by polyclonal antisera directed against peptides derived from a homologue of Plasmodium falciparum apical membrane antigen 1. Gaffar FR, Yatsuda AP, Franssen FF, de Vries E, Infect Immun 2004 72 2947 2955 10.1128/IAI.72.5.2947-2955.2004 15102807 (Pubitemid 38542425)
50. Apical membrane antigen 1 is a cross-reactive antigen between Neospora caninum and Toxoplasma gondii, and the anti-NcAMA1 antibody inhibits host cell invasion by both parasites. Zhang H, Compaore MK, Lee EG, Liao M, Zhang G, Sugimoto C, Fujisaki K, Nishikawa Y, Xuan X, Mol Biochem Parasitol 2007 151 205 212 10.1016/j.molbiopara.2006.11.005 17156863 (Pubitemid 46054217)